TL;DR
- •Mood stabilizers (Lithium, Lamictal, Depakote) are first-line for bipolar disorder — preventing both manic and depressive episodes rather than treating one direction.
- •Lithium has the strongest evidence for suicide-prevention specifically and remains the gold standard for bipolar despite being a "boring" old drug.
- •Lamictal (lamotrigine) is often preferred for bipolar II / bipolar depression — fewer cognitive side effects than lithium but rare risk of serious rash (Stevens-Johnson syndrome).
- •Important interaction: Lamotrigine partially BLOCKS ketamine's antidepressant effect by inhibiting the glutamate release ketamine depends on. Patients on lamotrigine need physician coordination before starting ketamine.
- •For breakthrough depression on a mood stabilizer, ketamine is an option — but the lamotrigine interaction means timing and dosing need careful planning.
- •Mood stabilizers can also augment antidepressants in unipolar depression — adding lithium to an SSRI is a long-established treatment-resistant strategy.
How this class works
Mood stabilizers work through different mechanisms than antidepressants. Lithium (mechanism still partially understood) modulates inositol signaling, GSK-3, and several neurotransmitter systems. Lamictal is an anticonvulsant that stabilizes voltage-gated sodium channels and reduces glutamate release. Depakote also stabilizes sodium channels and affects GABA. All three prevent mood-cycle extremes — they don't produce the same kind of rapid antidepressant lift SSRIs do, but they reduce the frequency and severity of mood episodes over months.
Medications in this class
Tovani has detailed drug-interaction pages for 2 mood stabilizers. Click any to see the ketamine-interaction verdict, mechanism, and FAQ.
Why patients look for alternatives
- •Breakthrough depressive episode despite mood stabilizer
- •Persistent low-grade depression between mood episodes
- •Side effects (cognitive dulling on lithium, weight gain on Depakote, rash risk on Lamictal)
- •Lithium toxicity / narrow therapeutic window concerns
- •Pregnancy planning — Depakote contraindicated, Lithium and Lamictal complicated
- •Multiple medications needed for stabilization — looking for simplification
Where ketamine fits
Clinical indication
Treatment-resistant bipolar depression — specifically the depressive phase that mood stabilizers don't fully resolve. Ketamine has evidence in bipolar depression including in patients on mood stabilizers, but with one critical caveat: lamotrigine partially blocks ketamine's antidepressant effect.
Onset comparison
Mood stabilizers prevent episodes over months; ketamine resolves an acute depressive episode within hours. The two work on different time scales — they're typically complementary, not competing.
Contraindications and coordination
Lamotrigine specifically requires physician coordination — the glutamate-suppressing mechanism of lamotrigine partially neutralizes ketamine's glutamate-burst mechanism. This doesn't mean ketamine is impossible on lamotrigine, but it means dose, timing, and expectations all need to be discussed. Active mania (vs depression) is a contraindication for ketamine — ketamine should not be used during a manic phase. Active substance use disorder is also a general contraindication.
5-minute screening · Reviewed by a board-certified physician · FL & NJ
Other alternatives worth knowing about
Ketamine isn’t the only escalation path. These are the other options your physician may consider, depending on your history.
Adjust mood stabilizer dose or switch within class
Optimizing lithium level (0.6-1.0 mEq/L is typical maintenance), or switching from Depakote to Lamictal for the bipolar II / depressive subtype.
Add atypical antipsychotic
Abilify, Seroquel, Latuda, or Vraylar — several have specific FDA approval for bipolar depression. Most-evidence-based add-on to a mood stabilizer for breakthrough depression.
Cautious antidepressant trial
SSRIs/SNRIs in bipolar require caution — risk of inducing mania or rapid-cycling. Generally used only alongside a mood stabilizer, not as standalone.
TMS or ECT
TMS has growing evidence for bipolar depression. ECT remains the most effective treatment for severe bipolar depression and is sometimes the right choice over medication adjustments.
Frequently asked
Can ketamine help my bipolar depression?
Yes — ketamine has evidence for treatment-resistant bipolar depression including in patients on mood stabilizers. The critical caveat: if you're on lamotrigine, the lamotrigine partially blocks ketamine's effect by suppressing the glutamate release ketamine produces. This needs to be planned carefully with your physician — not a reason to avoid ketamine, but a reason to coordinate dosing.
Will my mood stabilizer protect me from ketamine causing mania?
Probably — mood stabilizers reduce mania risk significantly, which is part of why they're the foundation of bipolar care. Ketamine should not be used during an active manic phase regardless. Your physician will assess your current mood state during consultation before any ketamine session.
I'm on lithium with a stable level. Does ketamine affect lithium?
Direct interaction is minimal — lithium and ketamine work through different pathways. The coordination concern is more about renal function (lithium is renally cleared and ketamine's hemodynamic effects can transiently affect kidney perfusion). Your physician will check your lithium level and renal function before starting ketamine.
My doctor wants me to add lithium to my SSRI. Should I just try ketamine instead?
Augmentation with lithium added to an SSRI is a long-established treatment-resistant depression strategy with strong evidence. Ketamine is a different option with faster onset but different requirements (medical consultation, in-person companion for sessions, etc.). Reasonable patients choose either path; your doctor's suggestion suggests they think lithium-augmentation has the highest probability of helping you specifically. Both are valid escalation paths.
I have bipolar II and just depression episodes. Is ketamine appropriate?
For treatment-resistant bipolar II depression, ketamine has growing evidence. The depressive episode aspect is what ketamine treats; the bipolar diagnosis means coordination with your mood stabilizer regimen matters. Your physician will review your full picture including any lamotrigine use (which affects ketamine's efficacy as described above).
References
- Murrough JW et al. 2013, American Journal of Psychiatry. Ketamine RCT in treatment-resistant depression — 64% response vs 28% placebo, including patients with bipolar depression on mood stabilizers. PMID 23982301
- Sanacora G et al. 2017, JAMA Psychiatry. APA consensus statement on ketamine's effects in treatment-resistant depression including the bipolar-depression subset on mood stabilizer regimens. PMID 28249076